Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Vita Coco Company CEO Martin Roper and related family trusts sold 20,000 shares of common stock for approximately $40 per share under a pre-arranged trading plan.
Summary
- Martin Roper, Chief Executive Officer and Director of Vita Coco Company, Inc. (COCO), reported sales of common stock.
- A total of 20,000 shares of common stock were sold on September 18, 2025, across four separate transactions.
- Martin Roper directly sold 5,000 shares at a weighted average price of $40.006, retaining 334,297 direct shares.
- The Christopher G. Roper Exempt Family Trust sold 5,000 shares at a weighted average price of $40.009, retaining 268,806 shares.
- The Peter S. Roper Exempt Family Trust sold 5,000 shares at a weighted average price of $40.011, retaining 267,915 shares.
- The Thomas L. Roper Exempt Family Trust sold 5,000 shares at a weighted average price of $40.007, retaining 268,931 shares.
- All reported sales were executed pursuant to a Rule 10b5-1 trading plan, which was pre-arranged.
- Roper also holds 61,200 shares indirectly through a spouse.
- Derivative holdings include various non-qualified stock options with exercise prices ranging from $10.178 to $32.78, with different vesting schedules and expiration dates up to March 3, 2035.
Sentiment
Score: 5
Explanation: The CEO and related trusts executed pre-planned sales under a Rule 10b5-1 plan, which is a routine event and does not necessarily indicate a change in sentiment about the company's future prospects. The sale price is robust.
Positives
- The sales were conducted under a Rule 10b5-1 trading plan, indicating they were pre-scheduled and not based on new, material non-public information, which can mitigate concerns about insider selling.
- The shares were sold at a robust price point, averaging approximately $40 per share.
Negatives
- The reduction in direct and indirect equity ownership by the CEO and related family trusts, even if pre-planned, could be perceived negatively by some investors.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Sales of 5,000 shares each by the Christopher G. Roper Exempt Family Trust, Peter S. Roper Exempt Family Trust, and Thomas L. Roper Exempt Family Trust are considered related party transactions due to their familial relationship with the CEO.
Stakeholder Impact
- Shareholders may note the reduction in insider ownership, though the pre-arranged nature of the sales under a Rule 10b5-1 plan typically mitigates concerns about the underlying health or prospects of the company.
Key Dates
| Date | Description |
|---|---|
| 11/27/2022 | Start of vesting for 298,507 non-qualified stock options. |
| 03/10/2024 | Start of vesting for 46,875 non-qualified stock options. |
| 03/04/2025 | Start of vesting for 62,743 non-qualified stock options. |
| 09/18/2025 | Date of common stock sales transactions by Martin Roper and related trusts. |
| 09/22/2025 | Date the Form 4 was signed by Alison Klein, Attorney-in-Fact for Martin Roper. |
| 03/03/2026 | Start of vesting for 70,715 non-qualified stock options. |
| 09/19/2029 | Expiration date for 579,670 non-qualified stock options with an exercise price of $10.178. |
| 01/11/2031 | Expiration date for 40,950 non-qualified stock options with an exercise price of $10.178. |
| 10/21/2031 | Expiration date for 298,507 non-qualified stock options with an exercise price of $15. |
| 03/10/2033 | Expiration date for 46,875 non-qualified stock options with an exercise price of $16.91. |
| 03/04/2034 | Expiration date for 62,743 non-qualified stock options with an exercise price of $26.18. |
| 03/03/2035 | Expiration date for 70,715 non-qualified stock options with an exercise price of $32.78. |
Keywords
Vita Coco, COCO, Martin Roper, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Equity, Shares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.